Evaluation of the pharmacotherapeutic follow-up effectiveness in patients with dyslipidemia in the secondary health care in the Brazilian Unified Health System (SUS). Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 58, 2022. DOI: 10.1590/s2175-97902022e20400. Disponível em: https://periodicos.usp.br/bjps/article/view/205627.. Acesso em: 10 jun. 2024.